SCHEMBL631213

SCHEMBL631213

COc1cc(C=Cc2ccc(C=Cc3cc(OC)c(OC)c(OC)c3)cc2)cc(OC)c1OC

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 13/20 0.85
TUBB4A P04350 8/20 0.85
TUBB P07437 8/20 0.85
TUBA3C P0DPH7 8/20 0.85
TUBA1B P68363 8/20 0.85
TUBA4A P68366 8/20 0.85
TUBB4B P68371 8/20 0.85
TUBB3 Q13509 8/20 0.85
TUBB2A Q13885 8/20 0.85
TUBB8 Q3ZCM7 8/20 0.85
TUBA3E Q6PEY2 8/20 0.85
TUBA1A Q71U36 8/20 0.85
TUBA1C Q9BQE3 8/20 0.85
TUBB6 Q9BUF5 8/20 0.85
TUBB2B Q9BVA1 8/20 0.85
CYP19A1 P11511 1/20 0.81
NQO2 P16083 1/20 0.81
CYP1A1 P04798 2/20 0.76
CYP1A2 P05177 2/20 0.76
CYP1B1 Q16678 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6896671 1.00 TUBB1 (0.85) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4659251 1.00 TUBB1 (0.85) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4608533 0.93 CYP1A1 (0.79) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4608535 0.93 CYP1A1 (0.79) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL9186172 0.92 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1394054 0.92 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3834841 0.92 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL9186181 0.92 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1394056 0.92 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL9186173 0.92 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2420890-B1 Positive photosensitive resin composition, method for forming cured film and liquid crystal display device FUJIFILM CORP (JP) 2017-03-01 EP disclosed
EP-2613198-B1 PHOTOSENSITIVE RESIN COMPOSITION, OXIME SULFONATE COMPOUND, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORP (JP) 2016-12-28 EP disclosed
US-8728708-B2 Photosensitive resin composition, oxime sulfonate compound, method for forming cured film, cured film, organic EL display device, and liquid crystal display device FUJIFILM CORPORATION (JP) 2014-05-20 US disclosed
US-8628907-B2 Positive photosensitive resin composition, method for forming cured film, cured film, organic el display device and liquid crystal display device FUJIFILM CORPORATION (JP) 2014-01-14 US disclosed
US-20140005409-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2014-01-02 US disclosed
EP-2613198-A1 PHOTOSENSITIVE RESIN COMPOSITION, OXIME SULFONATE COMPOUND, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM Corporation (JP) 2013-07-10 EP disclosed
US-20130171415-A1 PHOTOSENSITIVE RESIN COMPOSITION, OXIME SULFONATE COMPOUND, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2013-07-04 US disclosed
US-20120045616-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2012-02-23 US disclosed
EP-2420890-A1 Positive photosensitive resin composition, method for forming cured film, cured film, organic el display device and liquid crystal display device Fujifilm Corporation (JP) 2012-02-22 EP disclosed
US-20100040978-A1 PHOTOSENSITIVE LITHOGRAPHIC PRINTING PLATE MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2010-02-18 US disclosed
US-20060128823-A1 Radiation curable inkjet recording ink, and method of producing planographic printing plate using same, and ink composition, inkjet recording method, printed material, method of producing a planographic printing plate, and planographic printing plate FUJI PHOTO FILM CO., LTD. 2006-06-15 US disclosed
EP-1657286-A2 Radiation curable ink jet ink, comprising a polymerisation initiation sensitising dye FUJI PHOTO FILM CO., LTD. (JP) 2006-05-17 EP disclosed
EP-1621598-A1 Divinylfluorenes. Agfa-Gevaert (BE) 2006-02-01 EP disclosed
EP-1621928-A1 Photopolymerizable composition. Agfa-Gevaert (BE) 2006-02-01 EP disclosed
EP-1037938-B1 Use of hyperbranched polymers or dendrimers having a particular group as thickening or gelling agent OREAL (FR) 2004-08-25 EP disclosed
US-20040042931-A1 Chemically sensitive sensor comprising arylene alkenylene oligomers OLIGOSENSE NV (BE) 2004-03-04 US disclosed
US-6572826-B1 Semiconductive coatings, based on doped pi-conjugated arylene alkenylene oligomers chromatography; chromatography, \"electronic nose or tongue\"; polyarylenevinylenes OLIGOSENSE NV (BE) 2003-06-03 US disclosed
US-6475495-B1 Hyperbranched polymers or dendrimers containing a particular group, preparation process, use and compositions comprising them L'OREAL, S.A. (FR) 2002-11-05 US disclosed
US-6042788-A FOR DETECTING ANALYTES IN GASEOUS OR LIQUID PHASE IN SOLUTIONS, CHARACTERISED IN THAT THE CHEMICALLY SENSITIVE SENSORS COMPRISE A CHEMICALLY SENSITIVE PROBE OF ARYLENE ALKENYLENE OLIGOMERS, ALONE OR IN A MIXTURE INTERUNIVERSITAIR MICRO-ELEKTRONICA CENTRUM (IMEC) (BE) 2000-03-28 US disclosed
EP-0878711-A1 Chemically sensitive sensor comprising arylene alkenylene oligomers INTERUNIVERSITAIR MICRO-ELEKTRONICA CENTRUM VZW (BE) 1998-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120045616-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE AND LIQUID CRYSTAL DISPLAY DEVICE PELP1, EED, ARCN1 TUBB1 3948/4885TUBB4A 3615/4885TUBB 4065/4885
US-20140005409-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE AND LIQUID CRYSTAL DISPLAY DEVICE STRA6, NR2E3, CRKL TUBB1 4617/4885TUBB4A 4307/4885TUBB 4433/4885
US-20130171415-A1 PHOTOSENSITIVE RESIN COMPOSITION, OXIME SULFONATE COMPOUND, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE OXER1, OXSR1, RAD51 TUBB1 3283/4885TUBB4A 4150/4885TUBB 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.